Thandeka Moyo to Antibodies, Neutralizing
This is a "connection" page, showing publications Thandeka Moyo has written about Antibodies, Neutralizing.
Connection Strength
1,016
-
Molecular Basis of Unusually High Neutralization Resistance in Tier 3 HIV-1 Strain 253-11. J Virol. 2018 07 15; 92(14).
Score: 0,508
-
HIV-1 Subtype C Tier 3 Viruses Have Increased Infectivity Compared to Tier 2 Viruses. AIDS Res Hum Retroviruses. 2020 12; 36(12):1010-1019.
Score: 0,149
-
Targeting the N332-supersite of the HIV-1 envelope for vaccine design. Expert Opin Ther Targets. 2020 06; 24(6):499-509.
Score: 0,144
-
Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies. Virology. 2017 01 15; 501:12-24.
Score: 0,114
-
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency. J Virol. 2015 May; 89(10):5264-75.
Score: 0,101